Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: "The article does not mention costs. The story provides absolute proportions of children who were overweight or obese at 5 or 7 years old. Groups compared included children of those mothers with normal glucose levels, children of those with a diabetes diagnosis who were treated, and children of those with high blood sugar levels who were not treated. Although it’s not entirely clear which group actually received treatment. The study does not mention any harms of treatment for high blood sugar, which could potentially include severe episodes of low blood sugar (if treated with insulin). Would also have been helpful to say more about the lifestyle/nutrition interventions and to note that they have not been found to cause harm, though the effects of materal stress/worry and the costs of blood glucose monitoring are not well studied. The story does not make it clear what type of evidence the findings are based on. For instance, it’s not clear if results are from a randomized trial (the gold standard) or some other study design. An astute reader may be able to infer that this is not a randomized clinical trial from the statement that data were ""analyzed"", but one also doesn’t know if the design was prospective or retrospective, which would add to knowledge about the strength of the study. The fact that we actually don’t know what treatment women actually got is also not clearly discussed. There is no obvious embellishment or mistatement about gestational diabetes. The article provides a brief, but accurate description of what it is. The lead line ""women who develop diabetes during pregnancy"" is somewhat misleading because without clarification of the often transient nature of gestational diabetes, readers could think it means Type II diabetes – women who develop and continue to have diabetes. It would be preferable to define and use the term gestational diabetes or pregnancy-related diabetes much earlier. There is a quote from a researcher at Northwestern University who apparently is not affiliated with the latest findings. The story mentions treatment approaches of gestational diabetes, including diet, exercise, and insulin, which are appropriate. The article does not note the option of not treating (especially in the lower range) which is advocated by some. Assuming ""treatment"" in this case is ""exercise, a special diet, or insulin,"" the article does imply that these are available. Most, if not all, people will understand that treatment for high blood sugar is readily available. What’s new is that treatment of women with blood sugar that is high, but not high enough for a diagnosis of diabetes, may benefit from treatment with exercise, diet, or insulin as well. A more important wrinkle in this particular study is that ""treatment"" is inferred by practice patterns used at Kaiser and no individual-level data is available to determine if the women in the group that would have been provided with counseling/intervention of gestational diabetes actually received that counsel or acted on it. Thus the ""treated group"" is actually those who met gestational diabetes criteria by National Diabetes Data Group criteria – thus they are really the treatment eligible group among whom some (likely large) group received some completely not specified treatment. Treatment for gestational diabetes is not new, although the story does not explicitly state this. What the story implies is that diagnosis and treatment of diabetes at lower blood sugar thresholds than those currently treated may have a benefit for children, although more studies are needed. Diagnosing and treating more pregnant women with high blood sugar who don’t necessarily meet the traditional diabetes diagnosis would be new and there is some discussion around this. Since the story used at least one independent perspective, it does not appear to have relied soley or largely on a news release."
Example Output: Diabetes care during pregnancy reduces risk of obese children

Example Input: The call was included in a state Health Department report on the adenovirus outbreak at the Wanaque Center for Nursing and Rehabilitation. “Ensuring that all staff are regularly trained in proper handwashing protocols and other infection control procedures is the best way to prevent the spread of respiratory viruses in long-term care facilities,” Health Commissioner Dr. Shereef Elnahal said in a statement. One staff member and 36 residents, ranging in age from toddlers to teens, were diagnosed with a particularly severe strain of adenovirus in the outbreak at the facility in Haskell, which provides care to children and adults. Eleven children died. The report recommended a new law that would require long-term care facilities to put in place detailed plans to prevent and respond to disease outbreaks. The department already has guidelines for the control of respiratory viral outbreaks but is calling for a statute to require such planning. Among the other recommendations was that parents and guardians should be notified “immediately following an event of significance.” Some parents of the infected children told newspapers that they didn’t learn about the outbreak until reading about it in news reports. On Thursday, Paul Fishman, an attorney working on behalf of the center, said Wanaque had already adopted the recommendations the state suggested. “Everybody recognizes that if they can prevent what happened, they will do what they can to prevent that,” Fishman said in a phone interview. The report follows the March announcement that the federal government fined the center $600,000 over what it said were lapses. Those included insufficient hand washing and problems with infection control procedures as well as a lack of involvement by the facility’s medical director and other management. The center disputed those findings and has said it planned an appeal. Adenovirus typically causes a mild cold or flu symptoms and usually poses little risk for healthy people. The strain found in the rehab center outbreak — type 7 — is among the more potent types and sometimes causes more serious respiratory illness, especially among those with weak immune systems. The children at the facility all had serious underlying health conditions, and many were on ventilators The first symptoms showed up Sept. 26, and the state was notified of an outbreak Oct. 9, officials said.
Example Output: State Health Department calls for requiring outbreak plan.

Example Input: Roehl, of Mandan, was 64 years old and had a state health insurance plan that covered the life-saving medication minus a $10 copay. But when he turned 65 and enrolled in Medicare, the price of the drug skyrocketed to $2,400 for a 30-day supply. Roehl, a retiree living on a fixed income, couldn’t afford the medication, so he stopped taking it. He was warned the leukemia — which was in remission — would come back. Then, a brochure came in the mail from a Canadian pharmacy advertising the drug for a fraction of the price — $684 for 30 days. He purchased a three-month supply and got it in the mail days later. “There are just so many inequities (in prescription drug prices),” he said. “To go from paying $10 to $2,400, that’s a tough pill to swallow.” Roehl joins an unknown number of North Dakotans who seek out lower drug prices in other countries, particularly Canada. Buying his medicine from across the border saves Roehl roughly $20,000 a year, The Bismarck Tribune reported. The pharmaceutical industry has long maintained that high drug prices are necessary to fund expensive research and development of new drugs. Federal and state legislation has been proposed in recent months to combat the rising cost of prescription drugs and to increase price transparency. In Congress, it remains to be seen what, if any, legislation could pass. Members of North Dakota’s all-Republican congressional delegation have signaled their support for various bipartisan measures making their way through Congress aimed at lowering prescription drug prices. These include the Prescription Drug Pricing Reduction Act, introduced by Sen. Chuck Grassley, R-Iowa, and Sen. Ron Wyden, D-Oregon, and the Lower Health Care Costs Act, introduced by Sen. Lamar Alexander, R-Tennessee, and Sen. Patty Murray, D-Washington. North Dakota Sen. John Hoeven said in a statement that two bills he co-sponsored to increase prescription drug price transparency and to “close existing loopholes hindering the development of generic drugs” were included in Alexander’s legislation. North Dakota Sen. Kevin Cramer said he also supports Alexander’s and Grassley’s bills, and Rep. Kelly Armstrong said he also has backed similar drug-pricing legislation in the House. None of these bills have made it to a floor vote. Buying from Canada Roger and Vicki Roehl thought they prepared for retirement. Both had successful careers: Roger Roehl headed the mapping section for the state Department of Transportation, and Vicki Roehl was a high school English teacher and a counselor. They had saved up for retirement and hoped to travel the world. “Haven’t done much of that,” Roger Roehl said. His leukemia diagnosis brought their travel plans to a halt. But the chemotherapy drug Gleevec has brought him and his wife newfound optimism. Roger Roehl is in “hematological remission,” meaning: “The blood is normal and will stay normal as long as I take this pill,” he said. “It’s working. It’s the silver bullet of leukemia,” he said, adding he’s been taking the pill for three years. Roger and Vicki Roehl now have to budget for a three-month supply of the drug and tap into their savings to afford it, even with the north-of-the-border savings. Purchasing prescriptions drugs from Canadian pharmacies is a phenomenon not commonly talked about in the United States. The U.S. Food and Drug Administration prohibits importing prescription drug medication, except for people who buy drugs in small amounts for personal use. The cost of prescription drugs is lower in Canada and some other countries because their governments run their health care systems and are able to negotiate prices with drug manufacturers. In researching buying prescription medications from Canada, Roger Roehl found that other North Dakotans do it, as well. He said he’s aware of a bus in Minot that takes groups of people across the border. Some states have enacted laws that allow for prescription drug importation from other states, but no such law exists in North Dakota. In July, the Trump administration announced plans to allow for pilot projects developed by states, pharmacies or drug manufacturers to import certain prescription medications from Canada. It’s unclear when these programs could be implemented, as the administration has to go through a rulemaking process that could take months to years. Price transparency In North Dakota, lawmakers are looking to jump-start legislation related to prescription drug price transparency. During an interim Health Care Committee meeting last week, the group’s chairman, Rep. George Keiser, R-Bismarck, proposed a bill draft modeled after drug transparency legislation that passed in Texas this year. The bill draft requires information be reported by drug manufacturers, pharmacy benefit managers and health insurance companies. Pharmacy benefit managers, or PBMs, are referred to as middlemen in the prescription drug supply chain who negotiate prices with drug manufacturers for health care companies. The bill would require manufacturers to report every time the price of their drugs rises more than 10% in a year or 40% or more over five calendar years. PBMs also would be required report data annually, including the amount of “rebates” they collect from manufacturers, and health insurance companies also would have to report data on prescription drug costs. The information would be submitted to the state Board of Pharmacy and then published on a public website. Committee members last week mostly expressed support for the proposed legislation, which still has a long way to go before it’s introduced during the 2021 legislative session. Keiser told the Tribune the bill likely will go through a number of amendments. “What this is attempting to do is begin to bring transparency to the marketplace and the justification for (increasing drug prices),” Keiser said. “The key to this legislation — the most important element for me — is, you want to increase (the cost of) a drug 10% within a year, that’s fine, just tell us why.” The data will in turn help state health policymakers understand the problem and look for solutions, according to Keiser. “The public doesn’t know what’s involved. But until we can provide information for policymakers and the public, we can’t take the next step,” he said. Several states have enacted laws in recent years related to prescription drug prices, according to the National Conference of State Legislatures. Keiser said his bill draft is the first of its kind in North Dakota. Lobbyists for the pharmaceutical industry contend that drug-pricing and transparency bills don’t result in actual savings for consumers, and that others in the supply chain, such as PBMs, contribute to price increases. ‘An important first step’ Josh Askvig, state director of AARP North Dakota, spoke in support of Keiser’s bill draft at the committee meeting last week. Prescription drug prices are “a very high priority” for his group and a recurring issue he hears among its members. Askvig cited data from his organization that shows the average annual cost of prescription drugs in North Dakota increased 58% from 2012 to 2017, while the average income for North Dakotans increased only 6.7%. AARP recently launched a nationwide campaign aimed at lowering prescription drug prices. Askvig said his organization and its members have been advocating for a number of reforms at the state and national level. “We know that states can’t solve the problem alone, but knowing this committee’s willingness to dig into this, we think, is an important first step,” Askvig said. ___ Information from: Bismarck Tribune, http://www.bismarcktribune.com
Example Output:
Some North Dakotans turn to Canada for prescription pills.